Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AngioDynamics to Hold Fiscal Second Quarter Financial Results Conference Call on Monday, December 20, 2004.


QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO ANGO Algemene Nederlandse Gehandicapten Organisatie (Dutch: Equal Opportunities for Persons with Disabilities) ) today announced that the company will release its fiscal second quarter results on Monday, December 20, 2004 after market close.

Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on December 20th to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (888) 804-7108 from the U.S., or for international callers, please dial (706) 634-1250.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the Web site for 14 days. A telephone replay will be available from 7:30 p.m. Eastern Time December 20, 2004 through 11:59 p.m. Eastern Time on December 22, 2005 by dialing (888) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 2682091.

About AngioDynamics

AngioDynamics, Inc. (www.angiodynamics.com) designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA PTA or parent-teacher association: see parent education.  dilation dilation /di·la·tion/ (di-la´shun)
1. the act of dilating or stretching.

2. dilatation.


di·la·tion
n.
1.
 catheters, thrombolytic thrombolytic /throm·bo·lyt·ic/ (throm?bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts.

thrombolytic

1. dissolving or splitting up a thrombus.

2. an agent that dissolves or splits up a thrombus.
 products, image-guided vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing  products, endovascular laser venous system products, as well as drainage products.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 14, 2004
Words:288
Previous Article:Pepsi Cola of Klamath Falls Unveils 172 Kilowatt Solar Electric System for 'Net Zero' Energy Use.
Next Article:Island Buffalo Head Home to the Plains.
Topics:



Related Articles
E-Z-EM Reports Record Sales for Fourth Quarter and Year for Fiscal 2004; Conference Call to Begin at 9:00 a.m. EDT Friday, July 30.
AngioDynamics Reports Fiscal First Quarter Sales up 23%, Net Earnings Increase Sharply; Conference Call to Begin Today at 4:30 P.M. ET.
E-Z-EM Reports Record Sales for First Fiscal Quarter of 2005; Conference Call to Begin at 10:00 A.M. EDT Friday, October 8, 2004.
AngioDynamics Reports Fiscal Second Quarter EPS up 50% to $0.09; Conference Call to Begin Today at 4:30 P.M. ET.
AngioDynamics to Hold Fiscal 2005 Fourth Quarter Financial Results Conference Call on Friday, July 22, 2005.
AngioDynamics Fiscal Fourth Quarter Operating Profit up 31% on 23% Increase in Net Sales; Fiscal Year 2005 Net Sales Top a Record $60 Million; Net...
AngioDynamics to Hold Fiscal 2006 Second Quarter Financial Results Conference Call on Monday, December 19, 2005.
AngioDynamics Net Income Up 60% on 30% Increase to Record Net Sales in Second Quarter of Fiscal 2006; Conference Call to Begin Today at 4:30 pm ET.
AngioDynamics Reports Record First Quarter Sales and Earnings.
AngioDynamics Reports Record Second Quarter Sales and Net Income.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles